As of 2026-03-16, the Intrinsic Value of Dexcom Inc (DXCM) is 65.40 USD. This Dexcom valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 64.24 USD, the upside of Dexcom Inc is 1.80%.
The range of the Intrinsic Value is 43.87 - 134.37 USD
Based on its market price of 64.24 USD and our intrinsic valuation, Dexcom Inc (DXCM) is undervalued by 1.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 43.87 - 134.37 | 65.40 | 1.8% |
| DCF (Growth 10y) | 63.43 - 186.01 | 92.74 | 44.4% |
| DCF (EBITDA 5y) | 60.85 - 86.31 | 72.62 | 13.0% |
| DCF (EBITDA 10y) | 74.95 - 109.36 | 90.50 | 40.9% |
| Fair Value | 45.89 - 45.89 | 45.89 | -28.56% |
| P/E | 65.36 - 114.40 | 81.94 | 27.5% |
| EV/EBITDA | 41.02 - 77.47 | 56.04 | -12.8% |
| EPV | 13.10 - 16.69 | 14.90 | -76.8% |
| DDM - Stable | 26.73 - 104.83 | 65.78 | 2.4% |
| DDM - Multi | 50.75 - 155.29 | 76.57 | 19.2% |
| Market Cap (mil) | 25,054.88 |
| Beta | 1.39 |
| Outstanding shares (mil) | 390.02 |
| Enterprise Value (mil) | 25,431.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.73% |
| Cost of Debt | 4.25% |
| WACC | 7.53% |